CTLA4 and neoplasm: As a result, current research is focusing on combining anti-PD-1 therapy with other immunotherapeutic approaches, such as CTLA-4, tumor vaccines, or adoptive T-cell therapies, in an effort to improve treatment efficacy in GBM [73].